Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 18776 - 18800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	MMP25	64386	upregulated	[Organoselenium Compounds binds to Copper] which results in increased expression of MMP25 mRNA	16p13.3	A21751
Copper	Approved Investigational	MMP3	4314	downregulated	[Disulfiram binds to Copper] which results in decreased expression of MMP3 mRNA	11q22.2	A21750
Copper	Approved Investigational	MMP3	4314	upregulated	[NSC 689534 binds to Copper] which results in increased expression of MMP3 mRNA	11q22.2	A21749
Copper	Approved Investigational	MND1	84057	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MND1 mRNA	4q31.3	A21749
Copper	Approved Investigational	MNS1	55329	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MNS1 mRNA	15q21.3	A21749
Copper	Approved Investigational	MOB3B	79817	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MOB3B mRNA	9p21.2	A21749
Copper	Approved Investigational	MOCOS	55034	upregulated	[NSC 689534 binds to Copper] which results in increased expression of MOCOS mRNA	18q12.2	A21749
Copper	Approved Investigational	MORF4L2	9643	upregulated	[NSC 689534 binds to Copper] which results in increased expression of MORF4L2 mRNA	Xq22.2	A21749
Copper	Approved Investigational	MOSPD2	158747	upregulated	[NSC 689534 binds to Copper] which results in increased expression of MOSPD2 mRNA	Xp22.2	A21749
Copper	Approved Investigational	MPI	4351	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MPI mRNA	15q24.1	A21749
Copper	Approved Investigational	MPP7	143098	upregulated	[NSC 689534 binds to Copper] which results in increased expression of MPP7 mRNA	10p12.1	A21749
Copper	Approved Investigational	MPPE1	65258	upregulated	[Disulfiram binds to Copper] which results in increased expression of MPPE1 mRNA	18p11.21	A21750
Copper	Approved Investigational	MPZL2	10205	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MPZL2 mRNA	11q24	A21749
Copper	Approved Investigational	MRI1	84245	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MRI1 mRNA	19p13.13	A21749
Copper	Approved Investigational	MRPL10	124995	downregulated	[Disulfiram binds to Copper] which results in decreased expression of MRPL10 mRNA	17q21.32	A21750
Copper	Approved Investigational	MRPL12	6182	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MRPL12 mRNA	17q25.3	A21749
Copper	Approved Investigational	MRPL16	54948	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MRPL16 mRNA	11q12.1	A21749
Copper	Approved Investigational	MRPL18	29074	downregulated	[Disulfiram binds to Copper] which results in decreased expression of MRPL18 mRNA	6q25.3	A21750
Copper	Approved Investigational	MRPL23	6150	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MRPL23 mRNA	11p15.5	A21749
Copper	Approved Investigational	MRPL4	51073	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MRPL4 mRNA	19p13.2	A21749
Copper	Approved Investigational	MRPL45	84311	downregulated	[Disulfiram binds to Copper] which results in decreased expression of MRPL45 mRNA	17q12	A21750
Copper	Approved Investigational	MRPS26	64949	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MRPS26 mRNA	20p13	A21749
Copper	Approved Investigational	MSH2	4436	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MSH2 mRNA	2p21-p16.3	A21749
Copper	Approved Investigational	MSH6	2956	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MSH6 mRNA	2p16.3	A21749
Copper	Approved Investigational	MSI2	124540	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MSI2 mRNA	17q22	A21749

Displaying entries 18776 - 18800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability